skip to Main Content
Dr. David Tuveson, pancreatic cancer researcher

Faces of Let’s Win: Dr. David Tuveson

Dr. David Tuveson, M.D., Ph.D., Director of the Lustgarten Foundation Pancreatic Research Laboratory at Cold Spring Harbor Laboratory, explains why pancreatic cancer is so difficult to treat.
Dr. Luis Diaz, pancreatic cancer researcher

An Immunotherapy Game Changer

Immunotherapy with Keytruda (pembrolizumab) is approved for use in cancer patients with certain genetic defects in their tumors.
Back To Top